Abilify Side Effects May Cause Fatal Heart-Rhythm. On April 13, 2004, the U.S. Food and Drug Administration (FDA) instructed Bristol-Myers Squibb to notify health care professionals of a revision to the warnings section of labeling for Abilify (aripiprazole), describing the potential increased risk of hyperglycemia and diabetes in … [Read more...]